Search PubMed⌕ Search

Biomedical subjects

C Richard Conti

Publications and source records attributed to C Richard Conti.

78 records · Page 5Linked to original sources
PubMed2002

Cardiovascular continuing medical education: what education do you want?

In summary, continuing medical education is not generic--it is highly specific. In my view, it does not matter how physicians obtain knowledge in their areas of expertise, only that they obtain the knowledge. Cardiovascular medicine textbooks and scientific journals form the core of our knowledge, but many other modes of education are available, including audio CDs and tapes and CD ROMs. Now, extensive information is available on the internet almost as soon as it is discussed at national meetings. One must be careful with these so-called "up to date" sources of education, since much of this early information has not been peer reviewed. Nonetheless, most of that information turns out to be useful.

Cardiology↗
PubMed2002

Ongoing and planned studies of enhanced external counterpulsation.

There is strong, continued interest in enhanced external counterpulsation (EECP) as evidenced by current, ongoing clinical trials. Many of these have been designed to support the current indications of EECP, mainly its application in the treatment of symptomatic coronary artery disease. An exciting area in this regard ishow EECP may help control blood glucose in patients with angina and diabetes mellitus. A variety of planned or ongoing exploratory studies are also helping to explain the mechanism of action behind EECP. Two clinical trials are now investigating a new indication for EECP in patients with congestive heart failure, including the important randomized Prospective Evaluation of EECP in Congestive Heart failure (PEECH) trial.

Clinical Trials as Topic↗
PubMed2002

Silent cardiac ischemia.

Between the extremes of those who have no coronary disease and those limited by it are those with documented ischemia but no symptoms. Treating these patients in the "murky middle" generates some important questions. Should we treat patients with no symptoms solely on the basis of test abnormalities? Can we make the asymptomatic person better? What interventions would we use to treat such a disorder? How do we justify the risk, inconvenience, and cost of these interventions? How do we measure the efficacy of our intervention? Treating the asymptomatic person can only be justified if we prevent future events through our intervention. The management of silent ischemia can serve as a model for handling other preventative measures. The following article describes the issues around silent cardiac ischemia and some of the insights obtained in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study.

Electrocardiography↗